$NTIC
NORTHERN TECHNOLOGIES INTERNATIONAL CORP

2016 Q3 Form 10-K Financial Statement

#000117184317007207 Filed on November 21, 2017

View on sec.gov

Income Statement

Concept 2016 Q3 2016 2015 Q3
Revenue $9.520M $32.93M $8.102M
YoY Change 17.5% 8.61% 9.83%
Cost Of Revenue $6.400M $22.32M $5.500M
YoY Change 16.36% 8.58% 11.79%
Gross Profit $3.120M $10.61M $2.606M
YoY Change 19.73% 8.67% 6.23%
Gross Profit Margin 32.77% 32.23% 32.16%
Selling, General & Admin $3.920M $14.49M $3.390M
YoY Change 15.63% 17.29% 21.94%
% of Gross Profit 125.64% 136.5% 130.09%
Research & Development $1.380M $4.725M $1.080M
YoY Change 27.78% 16.74% 4.85%
% of Gross Profit 44.23% 44.52% 41.44%
Depreciation & Amortization $210.0K $660.0K $160.0K
YoY Change 31.25% 24.42% 14.29%
% of Gross Profit 6.73% 6.22% 6.14%
Operating Expenses $4.090M $19.21M $3.540M
YoY Change 15.54% 5.17% 60.91%
Operating Profit -$970.0K $1.283M -$934.1K
YoY Change 3.85% -59.3% -468.88%
Interest Expense $1.140M $13.26K $1.130M
YoY Change 0.88% -36.73% -24.16%
% of Operating Profit 1.03%
Other Income/Expense, Net -$10.00K $0.00
YoY Change
Pretax Income -$1.710M -$570.0K $200.0K
YoY Change -955.0% -117.98% -88.64%
Income Tax $360.0K $626.1K $153.2K
% Of Pretax Income 76.6%
Net Earnings -$1.440M -$867.5K $4.515K
YoY Change -31993.69% -148.48% -99.64%
Net Earnings / Revenue -15.13% -2.63% 0.06%
Basic Earnings Per Share -$0.19 $0.00
Diluted Earnings Per Share -$158.8K -$0.19 $0.00
COMMON SHARES
Basic Shares Outstanding 4.538M
Diluted Shares Outstanding 4.538M 4.585M

Balance Sheet

Concept 2016 Q3 2016 2015 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.640M $5.640M $4.650M
YoY Change 21.29% 21.29% -41.88%
Cash & Equivalents $3.395M $3.400M $2.624M
Short-Term Investments $2.240M $2.240M $2.030M
Other Short-Term Assets $420.0K $420.0K $830.0K
YoY Change -49.4% -49.4% -30.83%
Inventory $7.711M $7.710M $7.468M
Prepaid Expenses $422.0K $411.5K
Receivables $5.550M $5.550M $4.670M
Other Receivables $1.620M $1.620M $1.650M
Total Short-Term Assets $20.94M $20.94M $19.28M
YoY Change 8.65% 8.61% -13.64%
LONG-TERM ASSETS
Property, Plant & Equipment $7.276M $7.280M $7.293M
YoY Change -0.24% -0.14% 12.58%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $19.84M $19.84M $20.54M
YoY Change -3.42% -11.55% -10.52%
Other Assets $92.87K $1.730M $130.7K
YoY Change -28.96% 32.06% -16.65%
Total Long-Term Assets $22.85M $30.13M $25.00M
YoY Change -8.58% -6.69% -1.04%
TOTAL ASSETS
Total Short-Term Assets $20.94M $20.94M $19.28M
Total Long-Term Assets $22.85M $30.13M $25.00M
Total Assets $51.07M $51.07M $51.57M
YoY Change -0.96% -0.97% -4.61%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.754M $2.750M $2.101M
YoY Change 31.06% 30.95% -5.57%
Accrued Expenses $1.240M $1.240M $1.570M
YoY Change -21.02% -21.02% -19.49%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.994M $3.990M $3.672M
YoY Change 8.78% 8.72% -17.79%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $3.994M $3.990M $3.672M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $6.540M $6.540M $6.690M
YoY Change -2.24% -2.24% -19.4%
SHAREHOLDERS EQUITY
Retained Earnings $33.66M $34.52M
YoY Change -2.51% 5.47%
Common Stock $13.89M $13.53M
YoY Change 2.64% 6.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $44.53M $44.53M $44.87M
YoY Change
Total Liabilities & Shareholders Equity $51.07M $51.07M $51.57M
YoY Change -0.96% -0.97% -4.61%

Cashflow Statement

Concept 2016 Q3 2016 2015 Q3
OPERATING ACTIVITIES
Net Income -$1.440M -$867.5K $4.515K
YoY Change -31993.69% -148.48% -99.64%
Depreciation, Depletion And Amortization $210.0K $660.0K $160.0K
YoY Change 31.25% 24.42% 14.29%
Cash From Operating Activities -$990.0K $2.056M -$800.0K
YoY Change 23.75% -370.47% -109.96%
INVESTING ACTIVITIES
Capital Expenditures -$200.0K $643.4K -$350.0K
YoY Change -42.86% -55.29% -71.07%
Acquisitions
YoY Change
Other Investing Activities -$10.00K -$220.0K $500.0K
YoY Change -102.0% -106.3% -103.83%
Cash From Investing Activities -$210.0K -$995.2K $140.0K
YoY Change -250.0% -152.35% -100.98%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $138.9K
YoY Change 470.45%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -40.00K -270.2K -470.0K
YoY Change -91.49% -68.94% -361.11%
NET CHANGE
Cash From Operating Activities -990.0K 2.056M -800.0K
Cash From Investing Activities -210.0K -995.2K 140.0K
Cash From Financing Activities -40.00K -270.2K -470.0K
Net Change In Cash -1.240M 790.1K -1.130M
YoY Change 9.73% -58.44% -81.38%
FREE CASH FLOW
Cash From Operating Activities -$990.0K $2.056M -$800.0K
Capital Expenditures -$200.0K $643.4K -$350.0K
Free Cash Flow -$790.0K $1.412M -$450.0K
YoY Change 75.56% -164.22% -104.87%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017 ntic Allocated Share Based Compensation Expense Estimate Fiscal Year Two
AllocatedShareBasedCompensationExpenseEstimateFiscalYearTwo
79800
CY2017 ntic Allocated Share Based Compensation Expense Estimate Next Fiscal Year
AllocatedShareBasedCompensationExpenseEstimateNextFiscalYear
159600
CY2016 ntic Cost Of Goods Sold As Percentage Of Product Sales
CostOfGoodsSoldAsPercentageOfProductSales
223201.56
CY2017Q3 ntic Deferred Joint Ventures Expenses
DeferredJointVenturesExpenses
15200
CY2016Q3 ntic Deferred Joint Ventures Expenses
DeferredJointVenturesExpenses
54200
CY2017 ntic Defined Contribution Plan Maximum Amount Of Employees Contributions Percent
DefinedContributionPlanMaximumAmountOfEmployeesContributionsPercent
0.5
CY2017 ntic Effective Income Tax Rate Reconciliation Dividends Received Amount
EffectiveIncomeTaxRateReconciliationDividendsReceivedAmount
3159000
CY2016 ntic Effective Income Tax Rate Reconciliation Dividends Received Amount
EffectiveIncomeTaxRateReconciliationDividendsReceivedAmount
2681000
CY2017Q3 ntic Entity Wide Trade Joint Venture Receivables Four Joint Venturespercentage
EntityWideTradeJointVentureReceivablesFourJointVenturespercentage
0.607
CY2016Q3 ntic Entity Wide Trade Joint Venture Receivables Four Joint Venturespercentage
EntityWideTradeJointVentureReceivablesFourJointVenturespercentage
0.558
CY2017 ntic Fees For Services Provided To Joint Ventures
FeesForServicesProvidedToJointVentures
5452687
CY2016 ntic Fees For Services Provided To Joint Ventures
FeesForServicesProvidedToJointVentures
5137710
CY2017Q3 ntic Fees Receivable For Services Provided To Joint Ventures Current
FeesReceivableForServicesProvidedToJointVenturesCurrent
1302944
CY2016Q3 ntic Fees Receivable For Services Provided To Joint Ventures Current
FeesReceivableForServicesProvidedToJointVenturesCurrent
1406587
CY2017 ntic Increase Decrease In Fees Receivable For Services Provided To Joint Ventures
IncreaseDecreaseInFeesReceivableForServicesProvidedToJointVentures
-103643
CY2016 ntic Increase Decrease In Fees Receivable For Services Provided To Joint Ventures
IncreaseDecreaseInFeesReceivableForServicesProvidedToJointVentures
-42575
CY2017 ntic Increase Decrease In Trade Receivables Excluding Joint Ventures
IncreaseDecreaseInTradeReceivablesExcludingJointVentures
1092187
CY2016 ntic Increase Decrease In Trade Receivables Excluding Joint Ventures
IncreaseDecreaseInTradeReceivablesExcludingJointVentures
723798
CY2017 ntic Increase Decrease In Trade Receivables Joint Ventures
IncreaseDecreaseInTradeReceivablesJointVentures
-100151
CY2016 ntic Increase Decrease In Trade Receivables Joint Ventures
IncreaseDecreaseInTradeReceivablesJointVentures
146526
CY2017 ntic Net Sales Excluding Joint Ventures
NetSalesExcludingJointVentures
36346645
CY2016 ntic Net Sales Excluding Joint Ventures
NetSalesExcludingJointVentures
30211660
CY2017 ntic Net Sales To Joint Ventures
NetSalesToJointVentures
3222478
CY2016 ntic Net Sales To Joint Ventures
NetSalesToJointVentures
2721905
CY2017Q3 ntic Number Of Joint Venture Arrangements
NumberOfJointVentureArrangements
20
CY2017 ntic Number Of Stock Based Compensation Plans
NumberOfStockBasedCompensationPlans
2
CY2017 ntic Total Fees For Services Provided To Joint Ventures Geographic Location
TotalFeesForServicesProvidedToJointVenturesGeographicLocation
5452687
CY2016 ntic Total Fees For Services Provided To Joint Ventures Geographic Location
TotalFeesForServicesProvidedToJointVenturesGeographicLocation
5137710
CY2017Q3 ntic Trade Receivables Excluding Joint Ventures Net Current
TradeReceivablesExcludingJointVenturesNetCurrent
5912631
CY2016Q3 ntic Trade Receivables Excluding Joint Ventures Net Current
TradeReceivablesExcludingJointVenturesNetCurrent
4755320
CY2017Q3 ntic Trade Receivables Joint Ventures Current
TradeReceivablesJointVenturesCurrent
691752
CY2016Q3 ntic Trade Receivables Joint Ventures Current
TradeReceivablesJointVenturesCurrent
791903
CY2017 ntic Unrecognized Tax Benefits Increase Decrease Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreaseDecreaseResultingFromPriorPeriodTaxPositions
-4000
CY2016 ntic Unrecognized Tax Benefits Increase Decrease Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreaseDecreaseResultingFromPriorPeriodTaxPositions
15000
CY2017Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
2676610
CY2016Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
2753903
CY2017Q3 us-gaap Accrued Bonuses Current And Noncurrent
AccruedBonusesCurrentAndNoncurrent
1015000
CY2016Q3 us-gaap Accrued Bonuses Current And Noncurrent
AccruedBonusesCurrentAndNoncurrent
450000
CY2017Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3969267
CY2016Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3152808
CY2017Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2471064
CY2016Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3009617
CY2017Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
14163509
CY2016Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
13798567
CY2017 us-gaap Adjustment For Amortization
AdjustmentForAmortization
119033
CY2016 us-gaap Adjustment For Amortization
AdjustmentForAmortization
119032
CY2016 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
427437
CY2017 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
391664
CY2017Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
40000
CY2016Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
40000
CY2017Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
40000
CY2016Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
40000
CY2017Q3 us-gaap Assets
Assets
56612693
CY2016Q3 us-gaap Assets
Assets
51070050
CY2017Q3 us-gaap Assets Current
AssetsCurrent
26067618
CY2016Q3 us-gaap Assets Current
AssetsCurrent
20942171
CY2017Q3 us-gaap Assets Noncurrent
AssetsNoncurrent
23185413
CY2016Q3 us-gaap Assets Noncurrent
AssetsNoncurrent
22852007
CY2017Q3 us-gaap Available For Sale Securities
AvailableForSaleSecurities
3766984
CY2016Q3 us-gaap Available For Sale Securities
AvailableForSaleSecurities
2243864
CY2017Q3 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
3766984
CY2016Q3 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
2243864
CY2017Q3 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
6847177
CY2016Q3 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
6528252
CY2016Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3395274
CY2015Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2623981
CY2017Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6360199
CY2017 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
2964925
CY2016 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
771293
CY2017Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.02
CY2016Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.02
CY2017Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000
CY2016Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000
CY2017Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4535018
CY2016Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4533416
CY2017Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4535018
CY2016Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4533416
CY2017Q3 us-gaap Common Stock Value
CommonStockValue
90700
CY2016Q3 us-gaap Common Stock Value
CommonStockValue
90668
CY2017 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
3960679
CY2016 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-696320
CY2017 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
516475
CY2016 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-278729
CY2017 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
4477154
CY2016 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-975049
CY2017 us-gaap Cost Of Goods Sold
CostOfGoodsSold
26316511
CY2016 us-gaap Cost Of Goods Sold
CostOfGoodsSold
22320156
CY2017 us-gaap Costmethod Investments Other Than Temporary Impairment
CostmethodInvestmentsOtherThanTemporaryImpairment
CY2016 us-gaap Costmethod Investments Other Than Temporary Impairment
CostmethodInvestmentsOtherThanTemporaryImpairment
1883668
CY2017 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
CY2016 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
CY2017 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
754000
CY2016 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
647000
CY2017 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
816000
CY2016 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
667000
CY2017 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
62000
CY2016 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
20000
CY2017 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-135000
CY2016 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
6000
CY2017 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
28000
CY2016 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-47000
CY2017 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-116000
CY2016 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-41000
CY2017Q3 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
289300
CY2016Q3 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
289900
CY2017 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-9000
CY2016 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
CY2017Q3 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
1317700
CY2016Q3 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
1332000
CY2017Q3 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
11624600
CY2016Q3 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
10823000
CY2017Q3 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
87000
CY2016Q3 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
95300
CY2017Q3 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
1756600
CY2016Q3 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
1639800
CY2017Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
2045900
CY2016Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
1929700
CY2017Q3 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
1756565
CY2016Q3 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
1639762
CY2017Q3 us-gaap Deferred Tax Assets Other Tax Carryforwards
DeferredTaxAssetsOtherTaxCarryforwards
3473100
CY2016Q3 us-gaap Deferred Tax Assets Other Tax Carryforwards
DeferredTaxAssetsOtherTaxCarryforwards
3214300
CY2017Q3 us-gaap Deferred Tax Assets Tax Credit Carryforwards Foreign
DeferredTaxAssetsTaxCreditCarryforwardsForeign
6105700
CY2016Q3 us-gaap Deferred Tax Assets Tax Credit Carryforwards Foreign
DeferredTaxAssetsTaxCreditCarryforwardsForeign
5679000
CY2017Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
310300
CY2016Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
150600
CY2017Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
241600
CY2016Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
210600
CY2017Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther
74000
CY2016Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther
87000
CY2017Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
9578700
CY2016Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
8893300
CY2017Q3 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
83300
CY2016Q3 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
74300
CY2017Q3 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
206000
CY2016Q3 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
215600
CY2017 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
202559
CY2016 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
215785
CY2017 us-gaap Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
0.035
CY2017 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Percent
DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
0.15
CY2017 us-gaap Depreciation
Depreciation
787111
CY2016 us-gaap Depreciation
Depreciation
660008
CY2017 us-gaap Description Of New Accounting Pronouncements Not Yet Adopted
DescriptionOfNewAccountingPronouncementsNotYetAdopted
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" FONT-SIZE: 10pt; MARGIN: 0pt 0px"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.</div> RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS</div></div> <div style=" FONT-SIZE: 10pt; MARGIN: 0pt 0px">&nbsp;</div> <div style=" FONT-SIZE: 10pt; MARGIN: 0pt 0px">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May 2014, </div>the Financial Accounting Standards Board (FASB) issued <div style="display: inline; font-style: italic;">Revenue from Contracts with Customers, Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606</div></div> (Accounting Standards Update (ASU) <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09</div>), which provides a framework for the recognition of revenue, with the objective that recognized revenues properly reflect amounts an entity is entitled to receive in exchange for goods and services. This guidance, which includes additional disclosure requirements regarding revenue, cash flows and obligations related to contracts with customers, was originally to be effective for the Company beginning in fiscal year <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018.</div> In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 2015, </div>the FASB confirmed a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div>-year deferral of the effective date of the new revenue standard which also allows early adoption as of the original effective date. The updated guidance will be effective for the Company&#x2019;s <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> quarter of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019.</div> The Company is currently evaluating the impact of adopting ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09</div> on its consolidated financial statements, but currently believes that the timeline established for implementation is attainable.</div> <div style=" FONT-SIZE: 10pt; MARGIN: 0pt 0px">&nbsp;</div> <div style=" FONT-SIZE: 10pt; MARGIN: 0pt 0px">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 2015, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11,</div> &#x201c;<div style="display: inline; font-style: italic;">Inventory</div>&#x201d;, which modifies the subsequent measurement of inventories recorded under a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div>-in-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div>-out or average cost method. Under the new standard, such inventories are required to be measured at the lower of cost and net realizable value. The new standard is effective for the Company&#x2019;s fiscal year <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018,</div> with prospective application. The Company does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> expect the adoption of the provisions of ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11</div> to have a material impact on its consolidated financial statements.</div> <div style=" FONT-SIZE: 10pt; MARGIN: 0pt 0px"></div><div style="PAGE-BREAK-BEFORE: always; MARGIN-TOP: 6pt"> </div> <div style=" FONT-SIZE: 10pt; MARGIN: 0pt 0px">&nbsp;</div> <div style=" FONT-SIZE: 10pt; MARGIN: 0pt 0px">During <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> February 2016, </div>the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02,</div> &#x201c;<div style="display: inline; font-style: italic;">Leases</div>.&#x201d; ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02</div> was issued to increase transparency and comparability among organizations by recognizing all lease transactions (with terms in excess of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12</div> months) on the balance sheet as a lease liability and a right-of-use asset (as defined). ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02</div> is effective for fiscal years beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 15, 2018, </div>including interim periods within those fiscal years, with earlier application permitted. Upon adoption, the lessee will apply the new standard retrospectively to all periods presented or retrospectively using a cumulative effect adjustment in the year of adoption. The Company is currently assessing the effect that ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02</div> will have on its consolidated financial statements.</div> <div style=" FONT-SIZE: 10pt; MARGIN: 0pt 0px">&nbsp;</div> <div style=" FONT-SIZE: 10pt; MARGIN: 0pt 0px">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 2016, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">07,</div> &#x201c;<div style="display: inline; font-style: italic;">Investments &#x2013; Equity Method and Joint Ventures (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">323</div>): Simplifying the Transition to the Equity Method of Accounting</div>.&#x201d; Among other things, the amendments in ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">07</div> eliminate the requirement that when an investment qualifies for use of the equity method as a result of an increase in the level of ownership interest or degree of influence, an investor must adjust the investment, results of operations, and retained earnings retroactively on a step-by-step basis as if the equity method had been in effect during all previous periods that the investment had been held. The amendments require that the equity method investor add the cost of acquiring the additional interest in the investee to the current basis of the investor&#x2019;s previously held interest and adopt the equity method of accounting as of the date the investment becomes qualified for equity method accounting. Therefore, upon qualifying for the equity method of accounting, <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> retroactive adjustment of the investment is required. The amendments require that an entity that has an available-for-sale equity security that becomes qualified for the equity method of accounting recognize through earnings the unrealized holding gain or loss in accumulated other comprehensive income at the date the investment becomes qualified for use of the equity method. The amendments are effective for all entities for fiscal years, and interim periods within those fiscal years, beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 15, 2016. </div>The amendments should be applied prospectively upon their effective date to increases in the level of ownership interest or degree of influence that result in the adoption of the equity method. Early adoption is permitted. The Company is currently assessing the impact that ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">07</div> will have on its consolidated financial statements.</div> <div style=" FONT-SIZE: 10pt; MARGIN: 0pt 0px">&nbsp;</div> <div style=" FONT-SIZE: 10pt; MARGIN: 0pt 0px">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 2016, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09,</div> <div style="display: inline; font-style: italic;">Stock Compensation</div>, which is intended to simplify several aspects of the accounting for share-based payment award transactions. The guidance will be effective for the fiscal year beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 15, 2016, </div>including interim periods within that year. The Company is currently assessing the impact that ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09</div> will have on its consolidated financial statements.</div> <div style=" FONT-SIZE: 10pt; MARGIN: 0pt 0px">&nbsp;</div> <div style=" FONT-SIZE: 10pt; MARGIN: 0pt 0px">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August 2016, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,</div> <div style="display: inline; font-style: italic;">Statement of Cash Flows, Classification of Certain Cash Receipts and Cash Payments</div>&nbsp;&nbsp;ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15</div> eliminates the diversity in practice related to the classification of certain cash receipts and payments for debt prepayments or extinguishment costs, the maturing of a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">zero</div> coupon bond, the settlement of contingent liabilities arising from a business combination, proceeds from insurance settlements, distributions from certain equity method investees and beneficial interests obtained in a financial asset securitization. ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15</div> designates the appropriate cash flow classification, including requirements to allocate certain components of these cash receipts and payments among operating, investing and financing activities. The guidance is effective for fiscal years beginning <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 15, 2017. </div>Early adoption is permitted. The Company is currently evaluating the effects of adopting ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15</div> on its consolidated financial statements, but the adoption is <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> expected to have a significant impact on its consolidated financial statements.</div> <div style=" FONT-SIZE: 10pt; MARGIN: 0pt 0px">&nbsp;</div> <div style=" FONT-SIZE: 10pt; MARGIN: 0pt 0px">Although there are several other new accounting pronouncements issued or proposed by the FASB, which the Company has adopted or will adopt, as applicable, the Company does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> believe any of these accounting pronouncements has had or will have a material impact on the Company&#x2019;s consolidated financial position or operating results.</div></div>
CY2017 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.76
CY2016 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.19
CY2017 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.75
CY2016 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.19
CY2017 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
63839
CY2016 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-18826
CY2017Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1540386
CY2016Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
938363
CY2017Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
239400
CY2017 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
6377054
CY2016 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
5503314
CY2017Q3 us-gaap Equity Method Investment Summarized Financial Information Assets
EquityMethodInvestmentSummarizedFinancialInformationAssets
55633891
CY2016Q3 us-gaap Equity Method Investment Summarized Financial Information Assets
EquityMethodInvestmentSummarizedFinancialInformationAssets
52407026
CY2017Q3 us-gaap Equity Method Investment Summarized Financial Information Current Assets
EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets
51518210
CY2016Q3 us-gaap Equity Method Investment Summarized Financial Information Current Assets
EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets
48922924
CY2017Q3 us-gaap Equity Method Investment Summarized Financial Information Current Liabilities
EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities
15118074
CY2016Q3 us-gaap Equity Method Investment Summarized Financial Information Current Liabilities
EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities
12433700
CY2017Q3 us-gaap Equity Method Investment Summarized Financial Information Equity
EquityMethodInvestmentSummarizedFinancialInformationEquity
40334607
CY2016Q3 us-gaap Equity Method Investment Summarized Financial Information Equity
EquityMethodInvestmentSummarizedFinancialInformationEquity
39872543
CY2017 us-gaap Equity Method Investment Summarized Financial Information Gross Profit Loss
EquityMethodInvestmentSummarizedFinancialInformationGrossProfitLoss
44861300
CY2016 us-gaap Equity Method Investment Summarized Financial Information Gross Profit Loss
EquityMethodInvestmentSummarizedFinancialInformationGrossProfitLoss
40440726
CY2017 us-gaap Equity Method Investment Summarized Financial Information Net Income Loss
EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
11839933
CY2016 us-gaap Equity Method Investment Summarized Financial Information Net Income Loss
EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
9534771
CY2017Q3 us-gaap Equity Method Investment Summarized Financial Information Noncurrent Liabilities
EquityMethodInvestmentSummarizedFinancialInformationNoncurrentLiabilities
181210
CY2016Q3 us-gaap Equity Method Investment Summarized Financial Information Noncurrent Liabilities
EquityMethodInvestmentSummarizedFinancialInformationNoncurrentLiabilities
100783
CY2017 us-gaap Equity Method Investment Summarized Financial Information Revenue
EquityMethodInvestmentSummarizedFinancialInformationRevenue
101261132
CY2016 us-gaap Equity Method Investment Summarized Financial Information Revenue
EquityMethodInvestmentSummarizedFinancialInformationRevenue
90646833
CY2017Q3 us-gaap Equity Method Investment Underlying Equity In Net Assets
EquityMethodInvestmentUnderlyingEquityInNetAssets
20035074
CY2016Q3 us-gaap Equity Method Investment Underlying Equity In Net Assets
EquityMethodInvestmentUnderlyingEquityInNetAssets
19840774
CY2017Q3 us-gaap Equity Method Investments
EquityMethodInvestments
20035074
CY2016Q3 us-gaap Equity Method Investments
EquityMethodInvestments
19840774
CY2017Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1322089
CY2016Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1278597
CY2017Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
5709636
CY2017 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-50000
CY2016 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
CY2017 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7807563
CY2016 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8232369
CY2017 us-gaap Gross Profit
GrossProfit
13252612
CY2016 us-gaap Gross Profit
GrossProfit
10613409
CY2017 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
5898908
CY2016 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
4743831
CY2017 us-gaap Income Loss Including Portion Attributable To Noncontrolling Interest
IncomeLossIncludingPortionAttributableToNoncontrollingInterest
4624098
CY2016 us-gaap Income Loss Including Portion Attributable To Noncontrolling Interest
IncomeLossIncludingPortionAttributableToNoncontrollingInterest
-572182
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
699519
CY2016 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
626120
CY2017 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
989000
CY2016 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
1620000
CY2017 us-gaap Income Tax Reconciliation Equity In Earnings Losses Of Unconsolidated Subsidiary
IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary
1998000
CY2016 us-gaap Income Tax Reconciliation Equity In Earnings Losses Of Unconsolidated Subsidiary
IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary
956000
CY2017 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
841000
CY2016 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
997000
CY2017 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
1591000
CY2016 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-195000
CY2017Q3 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
67133
CY2017Q3 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
66647
CY2017Q3 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
109209
CY2017 us-gaap Income Tax Reconciliation Minority Interest Income Expense
IncomeTaxReconciliationMinorityInterestIncomeExpense
143000
CY2016 us-gaap Income Tax Reconciliation Minority Interest Income Expense
IncomeTaxReconciliationMinorityInterestIncomeExpense
148000
CY2017 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
81000
CY2016 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
90000
CY2017 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
19000
CY2016 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
103000
CY2017 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
53000
CY2016 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
20000
CY2017 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
212000
CY2016 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
408000
CY2017 us-gaap Income Tax Reconciliation Tax Credits Foreign
IncomeTaxReconciliationTaxCreditsForeign
3680000
CY2016 us-gaap Income Tax Reconciliation Tax Credits Foreign
IncomeTaxReconciliationTaxCreditsForeign
3178000
CY2017 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
699519
CY2016 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
610000
CY2017Q3 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
137256
CY2016Q3 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
215905
CY2017 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-129371
CY2016 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
641631
CY2017 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-27297
CY2016 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
42984
CY2017 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
742869
CY2016 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-123924
CY2017 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
117298
CY2016 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
47000
CY2017 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-90926
CY2016 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
40859
CY2017 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-305268
CY2016 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
257826
CY2017 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-8454
CY2016 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-17023
CY2017 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
48748
CY2016 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
CY2017 us-gaap Interest Expense
InterestExpense
20382
CY2016 us-gaap Interest Expense
InterestExpense
13261
CY2017 us-gaap Interest Paid Net
InterestPaidNet
20382
CY2016 us-gaap Interest Paid Net
InterestPaidNet
13261
CY2016 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
68634
CY2017 us-gaap Profit Loss
ProfitLoss
3924579
CY2016 us-gaap Profit Loss
ProfitLoss
-1198302
CY2017Q3 us-gaap Liabilities Current
LiabilitiesCurrent
4894617
CY2016Q3 us-gaap Liabilities Current
LiabilitiesCurrent
3994102
CY2016Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
6258891
CY2017Q3 us-gaap Inventory Gross
InventoryGross
7456552
CY2016Q3 us-gaap Inventory Gross
InventoryGross
7711287
CY2017Q3 us-gaap Inventory Net
InventoryNet
7456552
CY2016Q3 us-gaap Inventory Net
InventoryNet
7711287
CY2017Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
1747189
CY2016Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
1452396
CY2017 us-gaap Investment Income Interest
InvestmentIncomeInterest
43539
CY2016 us-gaap Investment Income Interest
InvestmentIncomeInterest
42115
CY2017Q3 us-gaap Land
Land
310365
CY2016Q3 us-gaap Land
Land
310365
CY2017Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
56612693
CY2016Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
51070050
CY2017Q3 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
4171387
CY2016Q3 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
3590063
CY2017Q3 us-gaap Minority Interest
MinorityInterest
2857448
CY2016Q3 us-gaap Minority Interest
MinorityInterest
2540973
CY2016 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
200000
CY2017 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
200000
CY2017 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-226690
CY2016 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-270247
CY2017 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2607915
CY2016 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-995240
CY2017 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
5735691
CY2016 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2055606
CY2017 us-gaap Net Income Loss
NetIncomeLoss
3422126
CY2016 us-gaap Net Income Loss
NetIncomeLoss
-867514
CY2017 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
502453
CY2016 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-330788
CY2017Q3 us-gaap Noncurrent Assets
NoncurrentAssets
7359662
CY2016Q3 us-gaap Noncurrent Assets
NoncurrentAssets
8554469
CY2017Q3 us-gaap Number Of Countries In Which Entity Operates
NumberOfCountriesInWhichEntityOperates
60
CY2017 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
CY2017 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2017 us-gaap Operating Expenses
OperatingExpenses
20003266
CY2016 us-gaap Operating Expenses
OperatingExpenses
19212318
CY2017 us-gaap Operating Income Loss
OperatingIncomeLoss
4600941
CY2016 us-gaap Operating Income Loss
OperatingIncomeLoss
1282632
CY2017Q3 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
702427
CY2017Q3 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
264919
CY2017Q3 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
146635
CY2017Q3 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
47884
CY2017Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
677621
CY2016Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
301836
CY2017Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
71685
CY2016Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
92874
CY2017 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
552575
CY2016 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
223253
CY2017 us-gaap Other Operating Income
OtherOperatingIncome
11351595
CY2016 us-gaap Other Operating Income
OtherOperatingIncome
9881541
CY2017 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
196225
CY2016 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
138881
CY2017 us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
200000
CY2016 us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
200000
CY2017 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
3000000
CY2016 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
216423
CY2017 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
162525
CY2016 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
135410
CY2017 us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
0
CY2016 us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
0
CY2017 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
922270
CY2016 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
643407
CY2017Q3 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
0
CY2016Q3 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
0
CY2017Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000
CY2016Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000
CY2017Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2016Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2017Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2016Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2017Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2016Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2017Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
439298
CY2016Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
422031
CY2017 us-gaap Proceeds From Dividends Received
ProceedsFromDividendsReceived
6377054
CY2016 us-gaap Proceeds From Dividends Received
ProceedsFromDividendsReceived
5503314
CY2017 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
1476880
CY2016 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
CY2017 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
122999
CY2016 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
CY2017 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
46536
CY2017Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
11328929
CY2016Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
10428680
CY2017Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7359662
CY2016Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7275872
CY2017 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2912393
CY2016 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4724596
CY2017Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
6360201
CY2016Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
3395274
CY2017Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
37077483
CY2016Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
33655357
CY2017Q3 us-gaap Retained Earnings Undistributed Earnings From Equity Method Investees
RetainedEarningsUndistributedEarningsFromEquityMethodInvestees
17960860
CY2016Q3 us-gaap Retained Earnings Undistributed Earnings From Equity Method Investees
RetainedEarningsUndistributedEarningsFromEquityMethodInvestees
17779912
CY2017 us-gaap Revenue Recognition Deferred Revenue
RevenueRecognitionDeferredRevenue
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" FONT-SIZE: 10pt; MARGIN: 0pt 0px"><div style="display: inline; font-style: italic;">Net Sales </div>&#x2013;The Company includes net sales to its joint ventures and net sales to unaffiliated customers as separate line items on its consolidated statements of operations. There are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> sales originating from the Company&#x2019;s joint ventures included in the amount, as the Company&#x2019;s investments in its joint ventures are accounted for using the equity method.</div> <div style=" FONT-SIZE: 10pt; MARGIN: 0pt 0px">&nbsp;</div> <div style=" FONT-SIZE: 10pt; MARGIN: 0pt 0px"><div style="display: inline; font-style: italic;">Revenue Recognition</div> &#x2013; The Company recognizes revenue from the sale of its products when persuasive evidence of an arrangement exists, the product has been delivered, the price is fixed and determinable and collection of the resulting receivable is reasonably assured. These criteria are met when risk of loss and title pass to the customer, distributor or joint venture entity. Sales and use taxes charged to customers are reported on a net basis.</div></div></div></div></div></div>
CY2017 us-gaap Sales Revenue Net
SalesRevenueNet
39569123
CY2016 us-gaap Sales Revenue Net
SalesRevenueNet
32933565
CY2017 us-gaap Selling Expense
SellingExpense
9283310
CY2016 us-gaap Selling Expense
SellingExpense
6255353
CY2017 us-gaap Share Based Compensation
ShareBasedCompensation
391664
CY2016 us-gaap Share Based Compensation
ShareBasedCompensation
427437
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.46
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.466
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0163
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0163
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
221027
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
13.76
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
12000
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
20000
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
53447
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
56677
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
7.69
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
8.48
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1238009
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
241734
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
283181
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
307858
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
13.72
CY2016 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4537504
CY2017 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4528611
CY2016 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4537504
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
13.93
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
13.95
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
10.25
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
13.38
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
15.21
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
14.85
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
13.40
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P10Y
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P10Y
CY2017Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
942314
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y281D
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y167D
CY2016Q3 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
3029
CY2015Q3 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
2438
CY2017Q1 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
1098
CY2016Q1 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
3144
CY2017 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
12000
CY2016 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2016 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
68634
CY2017 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
46536
CY2017 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
122999
CY2017 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
391664
CY2016 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
427437
CY2015Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
3000000
CY2017Q3 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
2640548
CY2017 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
14525
CY2016 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
138881
CY2017 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
196225
CY2017Q3 us-gaap Stockholders Equity
StockholdersEquity
48860628
CY2016Q3 us-gaap Stockholders Equity
StockholdersEquity
44534975
CY2017Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
51718076
CY2016Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
47075948
CY2015Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
47893807
CY2017 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
13.51
CY2017Q3 us-gaap Undistributed Earnings Of Foreign Subsidiaries
UndistributedEarningsOfForeignSubsidiaries
17960860
CY2016Q3 us-gaap Undistributed Earnings Of Foreign Subsidiaries
UndistributedEarningsOfForeignSubsidiaries
17779912
CY2016Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
238000
CY2015Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
203000
CY2017Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
250000
CY2017Q3 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2016Q3 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2017 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
16000
CY2016 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
20000
CY2017 us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" FONT-SIZE: 10pt; MARGIN: 0pt 0px"><div style="display: inline; font-style: italic;">Use of Estimates</div> - The preparation of the financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</div> <div style=" FONT-SIZE: 10pt; MARGIN: 0pt 0px">&nbsp;</div> <div style=" FONT-SIZE: 10pt; MARGIN: 0pt 0px">Certain amounts reported in the consolidated financial statements for the previous reporting period have been reclassified to conform to the current period presentation. Expenses previously recorded as &#x201c;Expenses incurred in support of joint ventures&#x201d; have been reclassified as &#x201c;General and administrative expenses&#x201d; based on the reduction in direct costs associated with supporting the joint ventures.</div></div></div></div></div></div>
CY2017 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4577359

Files In Submission

Name View Source Status
0001171843-17-007207-index-headers.html Edgar Link pending
0001171843-17-007207-index.html Edgar Link pending
0001171843-17-007207.txt Edgar Link pending
0001171843-17-007207-xbrl.zip Edgar Link pending
exh_109.htm Edgar Link pending
exh_211.htm Edgar Link pending
exh_231.htm Edgar Link pending
exh_311.htm Edgar Link pending
exh_312.htm Edgar Link pending
exh_321.htm Edgar Link pending
exh_322.htm Edgar Link pending
f10k_112117p.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
lynch.jpg Edgar Link pending
ntic-20170831.xml Edgar Link completed
ntic-20170831.xsd Edgar Link pending
ntic-20170831_cal.xml Edgar Link unprocessable
ntic-20170831_def.xml Edgar Link unprocessable
ntic-20170831_lab.xml Edgar Link unprocessable
ntic-20170831_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
wolsfeld.jpg Edgar Link pending